ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/23
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by PfizerGlobeNewsWire • 12/21/22
ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/13/22
ORIC Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceGlobeNewsWire • 11/08/22
ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational UpdateGlobeNewsWire • 11/07/22
ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 11/03/22
ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational UpdateGlobeNewsWire • 08/11/22
ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 05/17/22
ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational UpdateGlobeNewsWire • 05/09/22
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 04/12/22
ORIC Pharmaceuticals, Inc.'s (ORIC) CEO Jacob Chacko on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/22/22
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational UpdateGlobeNewsWire • 03/21/22
ORIC Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Update Conference CallGlobeNewsWire • 03/17/22
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 03/08/22
ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology ConferenceGlobeNewsWire • 02/02/22